I am pointing out that the FDA's fallback position to save face on their prior comments is by giving an AA.
This destroys JB's arguments which his probable employer won't allow him to acknowledge it seems.
I expect full approval.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-300
-
- There are more pages in this discussion • 708 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.070(7.29%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
96.5¢ | $1.03 | 96.5¢ | $2.781M | 2.789M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 38823 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 8888 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 8889 | 1.025 |
18 | 80836 | 1.020 |
11 | 105975 | 1.015 |
11 | 107497 | 1.010 |
4 | 37978 | 1.005 |
Price($) | Vol. | No. |
---|---|---|
1.030 | 77526 | 14 |
1.035 | 28725 | 7 |
1.040 | 31414 | 3 |
1.045 | 4160 | 2 |
1.050 | 61000 | 3 |
Last trade - 11.51am 14/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online